HIGHLIGHTS
- who: Jutamas Shaughnessy and colleagues from the Boston University, United States have published the Article: An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae, in the Journal: (JOURNAL)
- what: Collectively, this study provides compelling evidence for increased PorB1B strain coverage with the optimized Fc3/FH* molecule. The authors show that Fc3/FH* retains its activity in_vitro after lyophilization, an important step in its development as an IVR-delivered drug.
- how: Data were acquired on a BD LSR II flow cytometer and data were analyzed using FlowJo software. Using C6-/- mice . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.